Gabexate mesilate vs aprotinin in human acute pancreatitis (GA.ME.P.A.) - A prospective, randomized, double-blind multicenter study

International Journal of Pancreatology

Volumn 14, Issue 2, 1993, Pages 117-124

  Pederzoli, Paolo ^a   Cavallini, Giorgio ^a   Falconi, Massimo ^a   Bassi, Claudio ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Acute pancreatitis; aprotinin; gabexate mesilate

Indexed keywords

APROTININ; GABEXATE MESILATE;

ACUTE HEMORRHAGIC PANCREATITIS; ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; BRONCHOSPASM; CARDIOVASCULAR DISEASE; DRUG ERUPTION; EDEMA; ERYTHEMA; FEMALE; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PERITONEUM EXUDATE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SEPSIS;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; APROTININ; DOUBLE-BLIND METHOD; FEMALE; GABEXATE; HUMAN; MALE; MIDDLE AGE; PANCREATITIS; PROSPECTIVE STUDIES;

EID: 0027367644     PISSN: 01694197     EISSN: 15590739     Source Type: Journal    
DOI: 10.1007/BF02786117     Document Type: Article

References (27)

1. Current concepts in the management of pancreatitis
2. A controlled trial of Trasylol in the treatment of acute pancreatitis
3. Death from acute pancreatitis. MRC multicenter trial of glucagon and aprotinin
4. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis
5. Morbidity of acute pancreatitis: the effect of aprotinin and glucagon
6. Treatment of acute pancreatitis. Comparison of animal and human studies
7. Continuous peritoneal dialysis in experimental acute pancreatitis in dogs. Effect of aprotinin in dialysate medium
8. Early graft injuries after pancreatic transplantation in syngenic rats. Cytoprotective effects of gabexate mesilate
9. Effective aprotinin therapy in canine experimental bile-trypsin pancreatitis
10. Gabexate mesilate (FOY), protects against ceruleine induced acute pancreatitis in the rat
11. The protective effect of the trypsin inhibitor urinastatin on cerulein induced acute pancreatitis in rats
12. The effects of nafamostat mesilate (FUT-175) on caerulein-induced acute pancreatitis in the rat
13. Effect of FOY-305 (camostate) on severe acute pancreatitis in two experimental animal models
14. Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, C1r and C1 esterase
15. Inhibition of phospholipase A2 by gabexate mesilate, camostate and aprotinin
16. Acute pancreatitis: prognostic value of CT
17. Kalikrein inhibitors
18. Studies on the influence of Trasylol on the partition of trypsin between the human plasma protease inhibitors in vitro
19. Gabexate mesilate and camostate: new inhibitors of phospholipase A2 and their influence on the alpha-amylase activity in serum of patients with acute pancreatitis
20. Effect of a new enzyme inhibitor (gabexate mesilate—FOY) on hyperenzymemia induced by ERCP. A doubleblind study
21. Gabexate mesilate (FOY) treatment of acute pancreatitis. An Italian multicenter pilot study
22. German Pancreatitis Study Group. Multicentre double blind study of gabexate mesilate (FOY) given intravenously in low dose in acute pancreatitis
23. Gabexate Mesilate in der Therapie der akuten Pancreatitis Multizenterstudie zur Vertaglichkeit einer hohen intravenosen Dosis (4 gr/Tag)
24. Comparative clinical study of FOY and Trasylol in acute pancreatitis
25. Gabexate mesilate in human acute pancreatitis: results from the German Multicenter Trial with 4 gr/day
26. Multicenter double-blind trial of gabexate mesilate (FOY) in Unselected Patients with acute pancreatitis